Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry

Objective: Here, we characterize differences in the genetic and microbial profiles of GC in patients of African (AFR), European, and Asian ancestry. Background: Gastric cancer (GC) is a heterogeneous disease with clinicopathologic variations due to a complex interplay of environmental and biological factors, which may affect disparities in oncologic outcomes.. Methods: We identified 1042 patients with GC with next-generation sequencing data from an institutional Integrated Mutation Profiling of Actionable Cancer Targets assay and the Cancer Genomic Atlas group. Genetic ancestry was inferred from markers captured by the Integrated Mutation Profiling of Actionable Cancer Targets and the Cancer Genomic Atlas whole exome sequencing panels. Tumor microbial profiles were inferred from sequencing data using a validated microbiome bioinformatics pipeline. Genomic alterations and microbial profiles were compared among patients with GC of different ancestries. Results: We assessed 8023 genomic alterations. The most frequently altered genes were TP53, ARID1A, KRAS, ERBB2, and CDH1. Patients of AFR ancestry had a significantly higher rate of CCNE1 alterations and a lower rate of KRAS alterations (P < 0.05), and patients of East Asian ancestry had a significantly lower rate of PI3K pathway alterations (P < 0.05) compared with other ancestries. Microbial diversity and enrichment did not differ significantly across ancestry groups (P > 0.05). Conclusions: Distinct patterns of genomic alterations and variations in microbial profiles were identified in patients with GC of AFR, European, and Asian ancestry. Our findings of variation in the prevalence of clinically actionable tumor alterations among ancestry groups suggest that precision medicine can mitigate oncologic disparities.

[1]  N. Schultz,et al.  Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort. , 2022, Cancer discovery.

[2]  M. Gonen,et al.  A Novel Microbiome Signature in Gastric Cancer , 2022, Annals of surgery.

[3]  K. Pradhan,et al.  The Genomics of Colorectal Cancer in Populations with African and European Ancestry , 2022, Cancer discovery.

[4]  L. K. Teixeira,et al.  Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability , 2021, Frontiers in Cell and Developmental Biology.

[5]  David R. Jones,et al.  Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients , 2021, Cell.

[6]  Yingtai Chen,et al.  Regional and racial disparity in proximal gastric cancer survival outcomes 1996–2016: Results from SEER and China National Cancer Center database , 2021, Cancer medicine.

[7]  D. Durocher,et al.  CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition , 2021, Nature.

[8]  David R. Jones,et al.  Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways , 2021, Clinical Cancer Research.

[9]  Allison P. Heath,et al.  The NCI Genomic Data Commons , 2021, Nature Genetics.

[10]  Laura H. Tang,et al.  Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies. , 2020, JAMA surgery.

[11]  M. Ladanyi,et al.  Abstract 6095: Unique tumor microbiome in microsatellite instability high (MSI-H) colon carcinoma , 2020 .

[12]  S. Raman,et al.  Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  Jeffrey S. Damrauer,et al.  Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer , 2020, Cancer Cell.

[14]  Daigo Hashimoto,et al.  Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. , 2020, The New England journal of medicine.

[15]  Kyoung-Mee Kim,et al.  CCNE1 amplification is associated with liver metastasis in gastric carcinoma. , 2019, Pathology, research and practice.

[16]  Laura H. Tang,et al.  Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype , 2019, The American journal of surgical pathology.

[17]  M. Mazumdar,et al.  Stage‐matched survival differences by ethnicity among gastric cancer patients of Asian ancestry treated in the United States , 2019, Journal of surgical oncology.

[18]  T. Rebbeck,et al.  Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers. , 2018, Cancer cell.

[19]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[20]  Jonathan M. Hernandez,et al.  Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer , 2018, Annals of Surgical Oncology.

[21]  Steven J. M. Jones,et al.  Oncogenic Signaling Pathways in The Cancer Genome Atlas. , 2018, Cell.

[22]  Michael T. Zimmermann,et al.  Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas , 2018, Cell reports.

[23]  M. Porembka,et al.  Gastric Cancer: Recent Molecular Classification Advances, Racial Disparity, and Management Implications. , 2018, Journal of oncology practice.

[24]  Laura H. Tang,et al.  Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients , 2017, Annals of surgery.

[25]  P. Kantoff,et al.  Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing , 2017, JAMA.

[26]  Donavan T. Cheng,et al.  Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing , 2017, BMC Medical Genomics.

[27]  Moriah H Nissan,et al.  OncoKB: A Precision Oncology Knowledge Base. , 2017, JCO precision oncology.

[28]  J. Ajani,et al.  Race Is a Risk for Lymph Node Metastasis in Patients With Gastric Cancer , 2017, Annals of Surgical Oncology.

[29]  S. Ikeda,et al.  Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors. , 2016, JAMA oncology.

[30]  G. Spolverato,et al.  Stage-Specific Prognostic Effect of Race in Patients with Resectable Gastric Adenocarcinoma: An 8-Institution Study of the US Gastric Cancer Collaborative. , 2016, Journal of the American College of Surgeons.

[31]  C. Yeh,et al.  Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients , 2016, Oncotarget.

[32]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[33]  Marc Peeters,et al.  Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer , 2015, Clinical Cancer Research.

[34]  Donavan T. Cheng,et al.  Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.

[35]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[36]  A. Bilchik,et al.  Race Influences Stage-specific Survival in Gastric Cancer , 2015, The American surgeon.

[37]  S. Brower,et al.  Race/Ethnicity Is Predictive of Lymph Node Status in Patients with Early Gastric Cancer , 2014, Journal of Gastrointestinal Surgery.

[38]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.

[39]  H. Liang,et al.  Clinical significance of lymph node metastasis in gastric cancer. , 2014, World journal of gastroenterology.

[40]  Kai Ye,et al.  MSIsensor: microsatellite instability detection using paired tumor-normal sequence data , 2014, Bioinform..

[41]  S. Gabriel,et al.  Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.

[42]  Su Jin Lee,et al.  Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients , 2013, Investigational New Drugs.

[43]  N. Hu,et al.  Comparison of Global Gene Expression of Gastric Cardia and Noncardia Cancers from a High-Risk Population in China , 2013, PloS one.

[44]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[45]  Carla Mattos,et al.  A comprehensive survey of Ras mutations in cancer. , 2012, Cancer research.

[46]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[47]  M. Ryu,et al.  Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum , 2012, British Journal of Cancer.

[48]  Adam M. Phillippy,et al.  Interactive metagenomic visualization in a Web browser , 2011, BMC Bioinformatics.

[49]  Laura H. Tang,et al.  Molecular Classification of Gastric Cancer: A New Paradigm , 2011, Clinical Cancer Research.

[50]  David H. Alexander,et al.  Fast model-based estimation of ancestry in unrelated individuals. , 2009, Genome research.

[51]  Chun Meng Song,et al.  Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. , 2009, European Journal of Cancer.

[52]  David R. Jones,et al.  Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer. , 2018, Cancer discovery.

[53]  W. Bossert,et al.  The Measurement of Diversity , 2001 .